Figure 1.
Waterfall plot of tumor reduction from baseline during the dose‐escalation and dose‐exploration phases (n = 18). Abbreviations: GI, gastrointestinal; IHBT, intrahepatic biliary tract; NSCLC, non‐small cell lung cancer; PD, progressive disease; PR, partial response; Q4W, once every 4 weeks; QW, once weekly; SD, stable disease.